ST. LOUIS — Missouri healthcare advocate Leslie Ortbals and her husband want to start a family, but she worries they can’t afford it. The 27-year-old said she takes 10 medications daily to manage multiple chronic illnesses. Now she worries the cost of those drugs could rise — not because of price increases, but because of
He was a surgical oncologist at a hospital in a Southern city, a 78-year-old whose colleagues had begun noticing troubling behavior in the operating room. During procedures, he seemed “hesitant, not sure of how to go on to the next step without being prompted” by assistants, said Mark Katlic, director of the Aging Surgeon Program
6 min read The following story contains spoilers for The Pitt season 2, episode 3, "9:00 A.M." PART OF THE fun of watching The Pitt—a fast-paced medical drama that takes place in real-time—is that we get to jump back and forth between all kinds of different medical predicaments, often with significantly differing levels of urgency.
4 min read The following story contains light spoilers for The Pitt season 2, episode 1, "8:00 AM." THERE ARE A lot of things that make The Pitt a fun show. Its fast-paced nature keeps us at full attention, its commitment to detail makes each case feel more realistic than just about anything else on
Dr Karina Volkova After Russian otorhinolaryngology (ENT) specialist Karina Volkova contacted Düsseldorf physician Rainer Frerich about a position in his practice, everything moved quickly. With a €1500 monthly subsidy from KV Nordrhein (the Association of Statutory Health Insurance Physicians for the North Rhine area) and a temporary professional permit issued by the Münster District Government
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f